Transferability of Economic Evaluations of Treatments for Advanced Melanoma-Reference-Cited by-同舟云学术

Transferability of Economic Evaluations of Treatments for Advanced Melanoma

Published:2019-11-25 Issue:2 Volume:38 Page:217-231
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Gorry Claire^ORCID,McCullagh Laura,Barry Michael

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40273-019-00860-y.pdf

Reference52 articles.

1. European Network for Health Technology Assessment, “About EUnetHTA—EUnetHTA,” 2019 (online). https://www.eunethta.eu/about-eunethta/. Accessed: 31 Jul 2019.

2. European Commission, Proposal for a regulation of the European Parliament and of the Council on Health Technology assessment and amending directive 2011/24/EU. European Commission, 2018.

3. Beneluxa, “Beneluxa initiative | BeNeLuxA,” 2019 (online). http://beneluxa.org/collaboration. Accessed: 31 Jul 2019.

4. Department of Health Ireland, “Press Release: Minister Harris signs international agreement aimed at securing affordable and timely access to new medicines for Irish patients | Department of Health”, 2018 (online). https://health.gov.ie/blog/press-release/minister-harris-signs-international-agreement-aimed-at-securing-affordable-and-timely-access-to-new-medicines-for-irish-patients/. Accessed: 18 Nov 2018.

5. McCullagh L, Barry M. The pharmacoeconomic evaluation process in Ireland. Pharmacoeconomics. 2016;34(12):1267–76.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of pharmacoeconomic studies of melanoma treatment for the period 2018–2023;South Russian Journal of Therapeutic Practice;2023-09-25

2. The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: a systematic review;BMC Primary Care;2023-02-06

3. The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: A systematic review;2022-12-15

4. Analisis del proceso de Evaluación de Tecnologías Sanitarias del Sistema de Protección Financiera Para Diagnósticos y Tratamientos de Alto Costo en Chile (Ley Ricarte Soto);Value in Health Regional Issues;2022-11

5. Cost-Utility of Nivolumab Plus Ipilimumab in First-Line Treatment of Advanced Melanoma in the United States: An Analysis Using Long-Term Overall Survival Data from Checkmate 067;PharmacoEconomics - Open;2022-08-25